Note: Effective October 17, 2018 the Company changed its name from TapImmune Inc. to Marker Therapeutics, Inc. and as such all references to “TapImmune” in the documents included herein should be replaced with “Marker” as the Company’s new name.

CODE OF ETHICS AND BUSINESS CONDUCT

We have adopted a Code of Ethics and Business Conduct that applies to all directors and officers. The code describes the legal, ethical and regulatory standards that must be followed by the directors and officers of the Company and sets forth high standards of business conduct applicable to each director and officer. A copy of the code can be viewed here.